Research tools
Analyst Ratings Screener
Find recent upgrades, downgrades, initiations, and reiterations by firm, rating, consensus, target upside, sector, and company size.
Save your best screens
Sign in to keep filters and sorting ready for your next visit.
4,057 matching rating changes
Export CSV| Date, sort lowest first | Symbol | Company | Firm | Action | Prior rating | New rating | Consensus | Analysts, sort highest first | Avg. target | Target upside, sort highest first | Market cap, sort highest first |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | ORCL | Oracle Corporation | Guggenheim | Reiterated | Buy | Buy | Buy | 32 | $319.08 | +108.32% | 560.97B |
| Sep 8, 2026 | OZK | Bank OZK | Morgan Stanley | Downgrade | Equal-Weight | Underweight | Hold | 14 | $57.50 | +17.90% | 5.53B |
| Sep 8, 2026 | OZKAP | Bank OZK | Morgan Stanley | Downgrade | Equal-Weight | Underweight | — | — | — | — | 1.86B |
| Sep 8, 2026 | PATH | UiPath Inc. | Citigroup | Initiated | — | Buy | — | — | $16.60 | +19.68% | 9.64B |
| Sep 8, 2026 | PB | Prosperity Bancshares, Inc. | Morgan Stanley | Downgrade | Equal-Weight | Underweight | — | — | $77.50 | +8.41% | 6.98B |
| Sep 8, 2026 | PDFS | PDF Solutions, Inc. | Morgan Stanley | Initiated | — | Overweight | — | — | $36.00 | -23.66% | 1.26B |
| Sep 8, 2026 | PDSB | PDS Biotechnology Corporation | HC Wainwright & Co. | Main | Buy | Buy | — | — | $9.00 | +2754.42% | 49.95M |
| Sep 8, 2026 | PGNY | Progyny, Inc. | Citizens | Main | Market Outperform | Market Outperform | Buy | 16 | $28.50 | +5.24% | 2.24B |
| Sep 8, 2026 | PHR | Phreesia, Inc. | Raymond James | Downgrade | Outperform | Market Perform | — | — | $30.56 | +200.49% | 961.63M |
| Sep 8, 2026 | PHVS | Pharvaris N.V. | Wedbush | Reiterated | Outperform | Outperform | — | — | $45.60 | +21.57% | 1.56B |
| Sep 8, 2026 | PHVS | Pharvaris N.V. | HC Wainwright & Co. | Reiterated | Buy | Buy | — | — | $45.60 | +21.57% | 1.56B |
| Sep 8, 2026 | PNFP | Pinnacle Financial Partners, Inc. | Morgan Stanley | Initiated | — | Overweight | — | — | $106.83 | +7.76% | 7.84B |
| Sep 8, 2026 | PNFPP | Pinnacle Financial Partners, Inc. | Morgan Stanley | Initiated | — | Overweight | — | — | — | — | 1.92B |
| Sep 8, 2026 | PSX | Phillips 66 | UBS | Main | Buy | Buy | Buy | 15 | $134.80 | -47.86% | 57.77B |
| Sep 8, 2026 | PTON | Peloton Interactive, Inc. | UBS | Main | Buy | Buy | Buy | 27 | $10.38 | +110.98% | 2.71B |
| Sep 8, 2026 | PTON | Peloton Interactive, Inc. | Morgan Stanley | Downgrade | Equal-Weight | Underweight | Buy | 27 | $10.38 | +110.98% | 2.71B |
| Sep 8, 2026 | RCUS | Arcus Biosciences, Inc. | Truist Securities | Reiterated | Buy | Buy | — | — | $29.50 | +12.81% | 2.72B |
| Sep 8, 2026 | RF | Regions Financial Corporation | Morgan Stanley | Main | Equal-Weight | Equal-Weight | — | — | $29.00 | -3.17% | 25.12B |
| Sep 8, 2026 | ROIV | Roivant Sciences Ltd. | Jefferies | Main | Buy | Buy | — | — | $23.50 | -42.60% | 14.83B |
| Sep 8, 2026 | ROIV | Roivant Sciences Ltd. | HC Wainwright & Co. | Main | Buy | Buy | — | — | $23.50 | -42.60% | 14.83B |
| Sep 8, 2026 | RPRX | Royalty Pharma plc | TD Cowen | Main | Buy | Buy | — | — | $47.00 | -20.00% | 16.85B |
| Sep 8, 2026 | RRC | Range Resources Corporation | Barclays | Main | Equal-Weight | Equal-Weight | Hold | 30 | $41.71 | -0.41% | 8.6B |
| Sep 8, 2026 | SAIA | Saia, Inc. | Citigroup | Main | Buy | Buy | — | — | $329.71 | -4.71% | 9.16B |
| Sep 8, 2026 | SAIC | Science Applications International Corporation | Goldman Sachs | Main | Sell | Sell | — | — | $111.40 | -13.48% | 4.6B |
| Sep 8, 2026 | SFNC | Simmons First National Corporation | Morgan Stanley | Downgrade | Equal-Weight | Underweight | — | — | $22.00 | -4.89% | 2.83B |
| Sep 8, 2026 | SG | Sweetgreen, Inc. | Keybanc | Upgrade | Sector Weight | Overweight | — | — | $10.25 | +51.63% | 852.28M |
| Sep 8, 2026 | SHAK | Shake Shack Inc. | RBC Capital | Initiated | — | Outperform | — | — | $126.22 | +104.57% | 3.19B |
| Sep 8, 2026 | SHOP | Shopify Inc. | Piper Sandler | Reiterated | Overweight | Overweight | Buy | 30 | $183.20 | +44.71% | 214.51B |
| Sep 8, 2026 | SIG | Signet Jewelers Limited | Stephens & Co. | Reiterated | Overweight | Overweight | — | — | $109.40 | +11.96% | 3.74B |
| Sep 8, 2026 | SLG | SL Green Realty Corp. | Barclays | Main | Equal-Weight | Equal-Weight | — | — | $56.00 | +8.46% | 3.18B |
| Sep 8, 2026 | SNPS | Synopsys, Inc. | Morgan Stanley | Upgrade | Equal-Weight | Overweight | Buy | 15 | $540.33 | +36.05% | 88.67B |
| Sep 8, 2026 | SNX | TD SYNNEX Corporation | Barclays | Main | Equal-Weight | Equal-Weight | Buy | 17 | $176.14 | -31.07% | 13.06B |
| Sep 8, 2026 | SPCX | AXS SPAC and New Issue ETF | Pivotal Research | Initiated | — | Buy | — | — | — | — | 8.9M |
| Sep 8, 2026 | SPCX | AXS SPAC and New Issue ETF | Wells Fargo | Main | Overweight | Overweight | — | — | — | — | 8.9M |
| Sep 8, 2026 | SRRK | Scholar Rock Holding Corporation | HC Wainwright & Co. | Reiterated | Buy | Buy | — | — | $49.50 | -11.08% | 4.78B |
| Sep 8, 2026 | ST | Sensata Technologies Holding plc | Barclays | Upgrade | Equal-Weight | Overweight | — | — | $38.50 | -8.75% | 5.24B |
| Sep 8, 2026 | STRC | MicroStrategy Incorporated Variable Rate Series A Perpetual Stretch Preferred Stock | Canaccord Genuity | Main | Buy | Buy | Buy | 22 | $252.00 | +157.22% | 28.45B |
| Sep 8, 2026 | STRD | MicroStrategy Incorporated 10.00% Series A Perpetual Stride Preferred Stock | Canaccord Genuity | Main | Buy | Buy | Buy | 22 | $231.50 | +208.13% | 953.41M |
| Sep 8, 2026 | STRK | MicroStrategy Incorporated | Canaccord Genuity | Main | Buy | Buy | — | — | — | — | 25.3B |
| Sep 8, 2026 | SVA | Sinovac Biotech Ltd. | HC Wainwright & Co. | Reiterated | Buy | Buy | — | — | — | — | 464.94M |
| Sep 8, 2026 | SYM | Symbotic Inc. | Barclays | Main | Underweight | Underweight | — | — | $65.11 | +58.42% | 38.43B |
| Sep 8, 2026 | SYRE | Spyre Therapeutics, Inc. | BTIG | Reiterated | Buy | Buy | — | — | $43.00 | -51.53% | 2.07B |
| Sep 8, 2026 | TARS | Tarsus Pharmaceuticals, Inc. Common Stock | Jefferies | Main | Buy | Buy | — | — | $84.75 | +4.47% | 3.47B |
| Sep 8, 2026 | TCRX | TScan Therapeutics, Inc. | HC Wainwright & Co. | Downgrade | Buy | Neutral | — | — | $7.50 | +2259.23% | 61.01M |
| Sep 8, 2026 | TEM | Tempus AI, Inc. | Rothschild & Co | Initiated | — | Neutral | Buy | 19 | $92.14 | +56.86% | 12.67B |
| Sep 8, 2026 | TEM | Tempus AI, Inc. | Roth Capital | Initiated | — | Neutral | Buy | 19 | $92.14 | +56.86% | 12.67B |
| Sep 8, 2026 | TH | Target Hospitality Corp. | Oppenheimer | Main | Outperform | Outperform | Buy | 12 | $9.75 | -49.01% | 873.07M |
| Sep 8, 2026 | TMDX | TransMedics Group, Inc. | TD Cowen | Reiterated | Buy | Buy | Buy | 20 | $148.00 | +74.04% | 4.37B |
| Sep 8, 2026 | UBER | Uber Technologies, Inc. | Wedbush | Reiterated | Outperform | Outperform | Buy | 31 | $116.06 | +59.95% | 177.6B |
| Sep 8, 2026 | UBER | Uber Technologies, Inc. | StoneX | Reiterated | Hold | Hold | Buy | 31 | $116.06 | +59.95% | 177.6B |
